Publications - 'B'
Publications 626 - 650 de 850
| Titre | DOI |
|---|---|
|
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text N. Bourdel; C. Huchon; A.W. Cendos; H. Azais; S. Bendifallah; P.A. Bolze; J.L. Brun; G. Canlorbe; P. Chauvet; E. Chereau; B. Courbiere; D.La Motte Rouge; M. Devouassoux-Shisheboran; C. Eymerit-Morin; R. Fauvet; E. Gauroy; T. Gauthier; M. Grynberg; M. Koskas; E. Larouzee; L. Lecointre; J. Leveque; F. Margueritte; M. D'argent; K. Nyangoh-Timoh; L. Ouldamer; J. Raad; E. Raimond; R. Ramanah; L. Rolland; P. Rousset; C. Rousset-Jablonski; I. Thomassin-Naggara; C. Uzan; M. Zilliox; E. Darai 2020 |
10.1016/j.gofs.2020.01.022 |
|
Boron Nitride Nanoporous Membranes with High Surface Charge by Atomic Layer Deposition M. Weber; B. Koonkaew; S. Balme; I. Utke; F. Picaud; I. Iatsunskyi; E. Coy; P. Miele; M. Bechelany 2017 |
10.1021/acsami.7b02883 |
|
Boron-doped nanoporous carbons as promising materials for supercapacitors and hydrogen storage N. Shcherban; S. Filonenko; P. Yaremov; V. Dyadyun; I. Bezverkhyy; V. Ilyin 2017 |
10.1007/s10853-016-0447-x |
|
Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia J. Fadlallah; M. Michel; E. Crickx; N. Limal; N. Costedoat; M. Malphettes; C. Fieschi; L. Galicier; E. Oksenhendler; B. Godeau; S. Audia; M. Mahevas 2019 |
10.1111/bjh.16009 |
|
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm L. Philippe; A. Ceroi; E. Bole-Richard; A. Jenvrin; S. Biichle; S. Perrin; S. Limat; F. Bonnefoy; E. Deconinck; P. Saas; F. Garnache-Ottou; F. Angelot-Delettre 2017 |
10.3324/haematol.2017.169326 |
|
Bortezomib Partially Improves Laminin alpha 2 Chain-Deficient Muscular Dystrophy Z. Korner; C.C. Fontes-Oliveira; J. Holmberg; V. Carmignac; M. Durbeej 2014 |
10.1016/j.ajpath.2014.01.019 |
|
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myelome B. Royer; S. Minvielle; M. Diouf; M. Roussel; L. Karlin; C. Hulin; B. Arnulf; M. Macro; S. Cailleres; A. Brion; S. Brechignac; K. Belhadj; M.Lorraine Chretien; M. Wetterwald; C. Chaleteix; M. Tiab; X. Leleu; L. Frenzel; L. Garderet; S. Choquet; J.Gabriel Fuzibet; C. Dauriac; L.M. Fornecker; L. Benboubker; T. Facon; P. Moreau; H. Avet-Loiseau; J.Pierre Marolleau 2016 |
10.1200/JCO.2015.63.1929 |
|
Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial P. Moreau; C. Hulin; M. Macro; D. Caillot; C. Chaieteix; M. Roussel; L. Garderet; B. Royer; S. Brechgnac; M. Tiab; M. Puyade; M. Escoffre; A.M. Stoppa; T. Facon; B. Pegourie; D. Chaoui; A. Jaccard; B. Slama; G. Marit; K. Laribi; P. Godmer; O. Luycx; J.Claude Eisenmann; O. Allangha; S. Claisner; M. Dib; C. Araujo; J. Fontan; K. Belhadj; M. Wetterwald; V. Dorvaux; J.P. Fermand; P. Rodon; B. Kolb; P. Lenain; L. Planche; L. Biron; H. Caillon; H. Avet-Loiseau; T. Dejoie; M. Attal 2015 |
|
|
Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial P. Moreau; C. Hulin; M. Macro; D. Caillot; C. Chaieteix; M. Roussel; L. Garderet; B. Royer; S. Brechgnac; M. Tiab; M. Puyade; M. Escoffre; A.M. Stoppa; T. Facon; B. Pegourie; D. Chaoui; A. Jaccard; B. Slama; G. Marit; K. Laribi; P. Godmer; O. Luycx; J.Claude Eisenmann; O. Allangha; S. Claisner; M. Dib; C. Araujo; J. Fontan; K. Belhadj; M. Wetterwald; V. Dorvaux; J.P. Fermand; P. Rodon; B. Kolb; P. Lenain; L. Planche; L. Biron; H. Caillon; H. Avet-Loiseau; T. Dejoie; M. Attal 2015 |
|
|
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study P. Moreau; M. Attal; C. Hulin; B. Arnulf; K. Belhadj; L. Benboubker; M.C. Bene; A. Broijl; H. Caillon; D. Caillot; J. Corre; M. Delforge; T. Dejoie; C. Doyen; T. Facon; C. Sonntag; J. Fontan; L. Garderet; K.S. Jie; L. Karlin; F. Kuhnowski; J. Lambert; X. Leleu; P. Lenain; M. Macro; C. Mathiot; F. Orsini-Piocelle; A. Perrot; A.M. Stoppa; N.W.C.J. van de Donk; S. Wuilleme; S. Zweegman; B. Kolb; C. Touzeau; M. Roussel; M. Tiab; J.P. Marolleau; N. Meuleman; M.C. Vekemans; M. Westerman; S.K. Klein; M.D. Levin; J.Paul Fermand; M. Escoffre-Barbe; J.R. Eveillard; R. Garidi; T. Ahmadi; S. Zhuang; C. Chiu; L. Pei; C. de Boer; E. Smith; W. Deraedt; T. Kampfenkel; J. Schecter; J. Vermeulen; H. Avet-Loiseau; P. Sonneveld 2019 |
10.1016/S0140-6736(19)31240-1 |
|
Both a single sacral marker and the whole-body center of mass accurately estimate peak vertical ground reaction force in running A. Patoz; T. Lussiana; B. Breine; C. Gindre; D. Malatesta 2021 |
10.1016/j.gaitpost.2021.07.013 |
|
Botrytis cinerea and Table Grapes: A Review of the Main Physical, Chemical, and Bio-Based Control Treatments in Post-Harvest N. De Simone; B. Pace; F. Grieco; M. Chimienti; V. Tyibilika; V. Santoro; V. Capozzi; G. Colelli; G. Spano; P. Russo 2020 |
10.3390/foods9091138 |
|
Bottlenecks to Financial Development, Financial Inclusion, and Microfinance: A Case Study of Mauritania M. Bouasria; A. Ashta; Z. Ratsimalahelo 2020 |
10.3390/jrfm13100239 |
|
Botulinium toxin and idiopathic overactive bladder: Multicentric contempory management in Bourgogne A. Schneider; B. Tourlonias; L. Cormier; E. Mourey; N. Koutlidis; E. Delorme; J. Pasquale; I. Kermarec; A.D. Foahom-Kamwa; V. Bonniaud 2018 |
10.1016/j.purol.2017.12.006 |
|
Botulinum Toxin in WW2 German and Allied Armies: Failures and Myths of Weaponization L. Tatu; J.P. Feugeas 2021 |
10.1159/000512812 |
|
Botulinum Toxin in WW2 German and Allied Armies: Failures and Myths of Weaponization L. Tatu; J.P. Feugeas Submitted |
10.1159/000512812, Early Access Date = {JAN 2021 |
|
Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study A. Levesque; S. Ploteau; F. Michel; L. Siproudhis; E. Bautrant; J. Eggermont; B. Rabischong; C. Volteau; M.A. Perrouin-Verbe; J.J. Labat 2021 |
10.1016/j.rehab.2019.12.009 |
|
Bound states for two dimensional Schrodinger equation with anisotropic interactions localized on a circle E. de Prunele 2015 |
10.1063/1.4907382 |
|
Boundary Control of Distributed Port-Hamiltonian Systems via Generalised Canonical Transformations A. Macchelli; Y. Le Gorrec; H. Ramirez 2017 |
|
|
Boundary Control of Distributed Port-Hamiltonian Systems via Generalised Canonical Transformations A. Macchelli; Y. Le Gorrec; H. Ramirez 2017 |
|
|
BOUNDARY CONTROLLABILITY AND BOUNDARY TIME-VARYING FEEDBACK STABILIZATION OF THE 1D WAVE EQUATION IN NON-CYLINDRICAL DOMAINS M. Yacine 2022 |
10.3934/eect.2021004 |
|
Boundary controlled irreversible port-Hamiltonian systems H. Ramirez; Y. Le Gorrec; B. Maschke 2022 |
10.1016/j.ces.2021.117107 |
|
Boundary Controlled Iterated Function Systems D. Sokolov; G. Gouaty; C. Gentil; A. Mishkinis 2015 |
10.1007/978-3-319-22804-4_29 |
|
Boundary Energy-Shaping Control of an Ideal Compressible Isentropic Fluid in 1-D A. Macchelli; Y. Le Gorrec; H. Ramirez 2017 |
10.1016/j.ifacol.2017.08.1105 |
|
Boundary energy-shaping control of an isothermal tubular reactor A. Macchelli; Y. Le Gorrec; H. Ramirez 2017 |
10.1080/13873954.2016.1232282 |